Related Experiment Video
Updated: Dec 10, 2025

04:57
Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
10.6K
A Predicting Nomogram for Mortality in Patients With COVID-19
Deng Pan1, Dandan Cheng2, Yiwei Cao1
1Department of Pulmonary and Critical Care Medicine, Affiliated Hospital of Qingdao University, Qingdao, China.
Frontiers in Public Health
|August 28, 2020
Summary
A new nomogram predicts COVID-19 patient mortality using C-reactive protein, PaO2/FiO2, and cTnI. This tool aids in identifying high-risk patients needing close monitoring during the severe global epidemic.
Area of Science:
- Medical research
- Infectious diseases
- Critical care medicine
Background:
- The COVID-19 pandemic poses a severe global health threat, with significant mortality rates.
- Accurate prediction of mortality is crucial for effective patient management and resource allocation.
Purpose of the Study:
- To develop and validate a reliable nomogram for predicting individual mortality risk in COVID-19 patients.
- To provide a clinical tool for early identification of patients requiring intensive care and close monitoring.
Main Methods:
- A retrospective single-center study involving 120 COVID-19 patients (21 deceased, 99 discharged) for nomogram construction.
- Validation of the nomogram using an independent cohort of 84 patients.
- Multivariable logistic regression analysis was employed to identify predictors and construct the model, followed by evaluation of calibration, differentiation, and clinical usefulness.
Main Results:
- The developed nomogram incorporates C-reactive protein, PaO2/FiO2 ratio, and cardiac troponin I (cTnI) as key predictors of mortality.
- The nomogram demonstrated high predictive accuracy with Areas Under the Curve (AUC) of 0.988 in the primary group and 0.956 in the validation group.
- Decision curve analysis indicated potential clinical utility for the nomogram in patient stratification.
Conclusions:
- A convenient and effective nomogram utilizing C-reactive protein, PaO2/FiO2, and cTnI has been developed to predict COVID-19 patient mortality.
- This tool can assist clinicians in assessing individual patient risk and guiding treatment decisions.
- Future research will focus on multi-center data collection to enhance the nomogram's reliability and generalizability.
Related Concept Videos
Dosage Regimen Designs: Nomograms and Tabulations
95
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
95
Actuarial Approach
219
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
219
Life Tables
379
A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
379
Cancer Survival Analysis
562
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
562
Comparing the Survival Analysis of Two or More Groups
462
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
462
Kaplan-Meier Approach
450
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
450

